Cancer / Oncology Clinical Trials

Alliance A011202

A randomized phase III trial evaluating the role of axillary lymph node dissection in breast cancer patients (ct1-3 n1) who have positive sentinel lymph node disease after neoadjuvant chemotherapy.

For more information, call (225) 237-1673.

MORD-RTPCR-0995

Procurement and research evaluation of human blood/body fluid and tissues for detection of occult malignancies using molecular assays and proteomics

For more information, call (225) 237-1673.

NSABP – B-51 / RTOG 1304

A randomized phase iii clinical trial evaluating post-mastectomy chest wall and regional nodal xrt and post-lumpectomy regional nodal xrt in patients with positive axillary nodes before neoadjuvant chemotherapy who convert to pathologically negative axillary nodes after neoadjuvant chemotherapy.

For more information, call (225) 237-1673.

For other cancer and oncology clinical trials and research opportunities, visit:
American Cancer Society
National Cancer Institute